• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Neovasc Inc (TSX: NVCN )

    N/A UNCHANGED
    Last Price Updated: 3:40 PM EDT, Apr 10, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 36.50 (1)
    Ask (Size) 65.50 (1)
    Prev. Close 40.15
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Neovasc Shareholders Approve Acquisition by Shockwave Medical
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire

    Performance

    More News

    Read More
    Neovasc Announces German Reimbursement Renewal
    Via NewMediaWire
    Neovasc (NASDAQ: NVCN) (TSX: NVCN) Enters into Agreement to be Acquired by Shockwave Medical (NASDAQ: SWAV) for $100 Million & CVR
    Via Spotlight Growth
    Exposures Product Safety
    Shockwave Medical Announces Agreement to Acquire Neovasc
    From Shockwave Medical, Inc.
    Via GlobeNewswire
    Neovasc Announces Progress on COSIRA-II Clinical Trial
    Via NewMediaWire
    Neovasc Comments on European Heart Journal Publication
    Via NewMediaWire
    Topics Intellectual Property
    Exposures Intellectual Property
    Neovasc Announces Third Quarter Financial Results and Provides Corporate Update
    Via NewMediaWire
    Neovasc Reducer Obtains U.S. Outpatient Reimbursement
    Via NewMediaWire
    Neovasc to Report Third Quarter Financial Results on November 10, 2022
    Via NewMediaWire
    Neovasc Provides Corporate Update Following Clinical Data Release
    Via NewMediaWire
    Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit
    Via NewMediaWire
    Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina
    Via NewMediaWire
    Neovasc Announces Key Events at TCT 2022
    Via NewMediaWire
    Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment Conference
    Via NewMediaWire
    Neovasc Announces Second Quarter Financial Results and Provides Corporate Update
    Via NewMediaWire
    Exposures Product Safety
    Neovasc to Report Second Quarter Financial Results on August 11, 2022
    Via NewMediaWire
    Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient Populations
    Via NewMediaWire
    Exposures Product Safety
    Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference
    Via NewMediaWire
    Neovasc to Participate in H.C. Wainwright Global Investment Conference
    Via NewMediaWire
    Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
    Via NewMediaWire
    Neovasc Announces First Quarter Financial Results and Provides Corporate Update
    Via NewMediaWire
    Neovasc to Report First Quarter Financial Results on May 12, 2022
    Via NewMediaWire
    Neovasc Comments on European Heart Journal Publication
    Via NewMediaWire
    Neovasc Announces Effective Date of Share Consolidation
    Via NewMediaWire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.